ABSTRACT

Cisplatin-vigorous hydration is required; can be nephrotoxic and ototoxic; can cause peripheral neuropathy; hold or reduce for creatinine >1.5

Mitotane-if well-tolerated, dose may be doubled on day 3; then,

from day 5 onwards, may increase dose by 500 mg every 2-3 days until maximum tolerated dose (8-12 grams daily) has been reached; glucocorticoid and mineralocorticoid replacement necessary to prevent adrenal insufficiency; increased steroid doses may be needed at times of physiologic stress

MS mitotane/ streptozocin

Mitotane 2000-4000 mg PO QD (in 4 divided doses)

Streptozocin 1000 mg IV days 1-5

-followed by 1500 to 2000 mg monthly maintenance

REF: Eriksson et al. Cancer 1987; 59:1398-1403

PREMEDICATIONS 1. Kytril 1 mg PO/IV 30 minutes before and 12 hours after

chemotherapy on days 1-5 2. Dexamethasone 10 mg IV 30 minutes before chemo­

therapy on days 1-5

OTHER MEDICATIONS 1. Give non-cisplatin delayed emesis prophylaxis

Streptozocin-vesicant-avoid extravasation; have 50% dextrose available in case of sudden hypoglycemia; monitor closely for renal impairment

I Mitotane-if well-tolerated, dose may be doubled on day 3; then, from day 5 onwards, may increase dose by 500 mg every 2-3 days until maximum tolerated dose (8-12 grams daily) has been reached; glucocorticoid and mineralocorticoid replacement necessary to prevent adrenal insufficiency; increased steroid doses may be needed at times of physiologic stress

Mitotane (o.p.-DDD)

Mitotane 6-15 mg/kg PO QD (in 3-4 divided doses)

REF: Wooten et al. Cancer 1993; 72:3145-3155

Mitotane-if well-tolerated, dose may be doubled on day 3; then, from day 5 onwards, may increase dose by 500 mg every 2-3 days until maximum tolerated dose (8-12 grams daily) has been reached; glucocorticoid and mineralocorticoid replacement necessary to prevent adrenal insufficiency; increased steroid doses may be needed at times of physiologic stress

Carcinoid and Islet Cell Carcinoma Agent Dosage CE cisplatin/ etoposide

Cisplatin 100 mg/M2 IV day 1 Etoposide 120 mg/M2 IV day 1

REF: Davis et al. Proc Am Soc Clin Oncol 1987; 6:73

PREMEDICATIONS 1. Kytril 1 mg PO/IV 30 minutes before and 12 hours after

chemotherapy 2. Dexamethasone 20 mg IV 30 minutes before chemo­

therapy

OTHER MEDICATIONS 1. Give cisplatin delayed-emesis prophylaxis

Repeat every 21 days

Cisplatin-vigorous hydration is required; can be nephrotoxic and ototoxic; can cause peripheral neuropathy; hold or reduce for creatinine > 1.5

Doxorubicin/ cisplatin

I Doxorubicin 50 mg/M2 IV day 1 ! Cisplatin 50 mg/M2 IV day 1

REF: Sridhar et al. Cancer 1985; 55:2634-2637

PREMEDICATIONS 1. Kytril 1 mg PO/IV 30 minutes before and 12 hours after

chemotherapy 2. Dexamethasone 20 mg IV 30 minutes before chemo­

therapy

OTHER MEDICATIONS 1. Give cisplatin delayed-emesis prophylaxis

Repeat every 21 -28 days

Cisplatin-vigorous hydration is required; can be nephrotoxic and ototoxic; can cause peripheral neuropathy; hold or reduce for creatinine >1.5

Doxorubicin-monitor cumulative dose for cardiac toxicity (not to exceed 550 mg/M2 or 450 mg/M2 with prior chest radiotherapy); vesicant-avoid extravasation; use 50% for bilirubin 1.5-3.0; use 25% for bilirubin > 3.0

Streptozocin/ doxorubicin

Streptozocin 500 mg/M2 IV days 1-5 Doxorubicin 50 mg/M2 IV days 1,22

REF: Moertel et al. NEJM 1992; 326:519-523

PREMEDICATIONS 1. Kytril 1 mg PO/IV 30 minutes before and 12 hours after

chemotherapy on days 1-5 and 22 2. Dexamethasone 10 mg IV 30 minutes before chemo­

therapy on days 1-5 and 22

OTHER MEDICATIONS 1. Give non-cisplatin delayed emesis prophylaxis

Repeat every 42 days

Streptozocin-vesicant-avoid extravasation; have 50% dextrose available in case of sudden hypoglycemia; monitor closely for renal impairment

Doxorubicin-monitor cumulative dose for cardiac toxicity (not to exceed 550 mg/M2 or 450 mg/M2 with prior chest radio­ therapy); vesicant-avoid extravasation; use 50% for bilirubin 1.5-3.0; use 25% for bilirubin > 3.0

Streptozocin/ fluorouracil (5-FU)

Streptozocin 500 mg/M2 IV days 1-5 5-FU 400 mg/M2 IV days 1-5

REF: Moertel et al. NEJM 1980; 303:1189-1194

PREMEDICATIONS 1. Kytril 1 mg PO/IV 30 minutes before and 12 hours after

chemotherapy on days 1-5 2. Dexamethasone 10 mg IV 30 minutes before chemo­

therapy on days 1-5

OTHER MEDICATIONS 1. Give non-cisplatin delayed emesis prophylaxis

Repeat every 42 days Streptozocin-vesicant-avoid extravasation; have 50% dextrose

available in case of sudden hypoglycemia; monitor closely for renal impairment

Agent Dosage CVD cyclophos­ phamide/ vincristine/ dacarbazine (DTIC)

Cyclophosphamide 750 mg/M2 IV day 1 Vincristine 1.4 mg/M2 IV day 1 DTIC 600 mg/M2 IV days 1,2

REF: Wu et al. Cancer 1994; 73:432-436

PREMEDICATIONS 1. Kytril 1 mg PO/IV 30 minutes before and 12 hours after

chemotherapy on days 1 and 2 2. Dexamethasone 20 mg IV 30 minutes before chemo­

therapy on days 1 and 2

Repeat every 21-28 days

Dacarbazine-vesicant-avoid extravasation

Vincristine-vesicant-avoid extravasation; cumulative neurotox­ icity-may produce severe constipation; maximum 2 mg per administration

Dacarbazine (DTIC)/ fluorouracil (5-FU)

DTIC 250 mg/M2 IV days 1-5 (over 15-30 min)

5-FU 450 mg/M2 IV days 1-5 (over 12 hours)

REF: Orlandi et al. Ann Oncol 1994; 5:763-765

PREMEDICATIONS 1. Kytril 1 mg PO/IV 30 minutes before and 12 hours after

chemotherapy on days 1-5 2. Dexamethasone 10 mg IV 30 minutes before chemo­

therapy on days 1-5

Repeat every 28 days (maximum of 6 cycles)

Agent Dosage CVD cyclophospha­ mide/ vincristine/ dacarbazine (DTIC)

Cyclophosphamide Vincristine DTIC

750 mg/M2 1.4 mg/M2

600 mg/M2

IV IV IV

day 1 day 1

days 1,2

REF: Averbuch et al. Ann Intern Med 1988; 109:267-273

PREMEDICATIONS 1. Kytril 1 mg PO/IV 30 minutes before and 12 hours after

chemotherapy on days 1 and 2 2. Dexamethasone 20 mg IV 30 minutes before chemo­

therapy on days 1 and 2

Repeat every 21-28 days

Dacarbazine-vesicant-avoid extravasation

Vincristine-vesicant-avoid extravasation; cumulative neurotoxicity-may produce severe constipation; maximum 2 mg per administration